Onchidin B : a new cyclodepsipeptide from the mollusc Onchidium sp. by Fernandez, R. et al.
Onchidin B: A New Cyclodepsipeptide 
from the Mollusc Onchidium sp. 
~ 
Rogelio Fernández, Jaime Rodriguez, Emilio Quiños, 
Ricardo Riguera, Luis Muñoz, Miryam Fernández-Suárez, 
and Cécile Debitus 
Contribution from the Departamento de Química Orgánica, 
Facultad de Química and Instituto de Acuicultura, 
Universidad de Santiago, E-1 5706, Santiago de Compostela, Spain, 
Departamento de Química Pura y Aplicada, Facultad de Ciencias, 
Universidad de Vigo, E-36200, Vigo, Spain, and Centre ORSTON, 
B. P. A5, Nouméa, Cedex, New Caledonia 
JOURNAL 
OF THE 
AMERICAN 
CHEMICAL socIEn@ 
Reprinted from 
Volume 11 8, Number 46, Pages 11 635-1 1643 
Fonds Documeashire I w B 
f 

J. Am. Chem. Soc. 1996,118, 11635-11643 11635 
Onchidin B: A New Cyclodepsipeptide from the Mollusc 
Onchìdium sp. 
Rogelio Fernández? Jaime Rodriguez>* Emilio Quiiioá? Ricardo Riguera,*s* 
Luis Muííoz: Miryam Fernández-Suárez: and Cécile Debitusl 
Contribution from the Departamento de Química Orgánica, Facultad de Química and Instituto de 
Acuicultura, Universidad de Santiago, E-15706, Santiago de Compostela, Spain, Departamento 
de Química Pura y Aplicada, Facultad de Ciencias, Universidad de Vigo, E-36200, Vigo, Spain, 
and Centre ORSTON, B. P. A5, Nouméa, Cedex, New Caledonia 
Received April 22, 199@ 
Abstract: Onchidin B (4) is a cyclic depsipeptide isolated from the pulmonate mollusc Onchidiuni sp. Its structure 
was determined by extensive 2D-NMR, FABMS, tandem FAB MS/MS, selective hydrolysis, and synthesis. It contains 
four a-amino acids [two units of N-methyl valine (MeVal), two units of proline (Pro)), four a-hydroxy acids [two 
2-hydroxyisovaleric acids (Hiv), two 2-hydroxy-3-methylpentanoic acid moieties (Hmp)] and two units of the new 
ß-hydroxy acid 3-hydroxy-2-methyloct-7-ynoic acid (Hymo)]. Selective hydrolysis and direct comparison by chiral 
GC-MS with authentic samples of the a-amino and a-hydroxy acids allowed us the assignment of the entire absolute 
stereochemistry of onchidin B. In this way, the a-hydroxy acids were found to be (8-Hiv and (S,S)-Hmp, and the 
a-amino acids (R)-proline, (S)-proline, and (R)-MeVal. In order to establish the absolute codiguration of the new 
ß-hydroxy acid, Hymo, its four possible stereoisomers were stereoselectively synthesized using chiral N-propionyl 
oxazolidinones and hex-5-ynal as starting material. Comparison by HPLC-MS of the synthetic samples with the 
natural Hymo (all derivatized as esters of (-)-(R)-a-methoxy-a-(9-anthryl)acetic acid), affirmed its absolute 
stereochemistry as (2R,3R). Thus, onchidin B (4) is cyclo [(R)-MeVal-(R,R)-Hymo-(S)-Pro-(S,S)-Hmp-(S)-Hiv-(R)- 
MeVal-(R,R)-Hymo-(R)-Pro-(S,S)-Hmp-(S)-Hiv]. It is formed by a head-to-tail linkage of two halves, each one 
built by five units and identical sequence. The lack of symmetry of onchidin B is thus due to the presence of one 
(5')-Pro unit in one half and one (R)-Pro unit in the other. The structural similarity between onchidin B (4) and 
onchidin (2), both isolated from the same organism, and between the ß-hydroxy acid Hymo (5) and the ß-amino 
acid Amo (3) found in onchidin is noticed. 
Introduction 
Natural products derived from marine organisms have become 
an increasingly important source of biologically active com- 
pounds. Some of the most interesting ones are the cyclic 
depsipeptides. This class of metabolites frequently offer an 
unrivaled chemical diversity incorporating new amino andor 
hydroxy acids. From a chemical point of view, this is one of 
the reasons why these compounds have attracted the effort of 
researchers resulting on the report of a fair number of new 
structures.' Most of the depsipeptides from marine organisms 
have been isolated from sponges; striking examples are the 
geodiamolides? arenastatin? and the antifungal and cytotoxic 
jasplakinolide (ja~pamide)?,~ 
On the other hand, only three molluscs have been found to 
be a source of cyclodepsipeptides. Pettit and co-workers have 
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isolated along the last ten years, more than a dozen dolastatins 
from Dolabella auricularia? Particularly important from the 
pharmacological point of view is the highly cytotoxic dolastatin 
10, the most potent antineoplastic agent known to date. It 
belongs to the selected group of marine natural products that 
are in clinical or preclinical stage as antitumoral compounds. 
Other marine molluscs that were reported to produce cyclic 
depsipeptides are Elysia ncfescens and Onchidium sp., collected 
in New Caledonia, from which kahalalide F (1)7 and onchidin 
(2)* were isolated, respectively. Onchidin constitutes the only 
example reported to date of a cyclic, symmetric depsipeptide 
from a mollusc. Its structure is composed of two identical 
halves: cyclo [(S)-N-methylvaline-(2S,3S)-3-amino-2-methyloct- 
7-ynoic acid-(S)-valine-(3-hydroxyisovaleric acid-(8-hydroxy- 
isovaleric acid12 linked together in a head-to-tail way so onchidin 
has a C2 axis of symmetry and, as a result, produces only half 
the expected NMR signals. In addition to known a-amino and 
a-hydroxy acids, onchidin (2) incorporates two identical units 
of the new ß-amino acid, 3-amino-2-methyloct-7-ynoic acid (3, 
We reported some time ago several polypropionate pyrones 
named on chi triol^.^ Those metabolites showed moderate anti- 
tumor activity and were isolated from the low polarity cytotoxic 
extracts of Onchidium sp. From this marine organism, we now 
Amo). 
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wish to report the bioassay guided isolation from the cytotoxic 
CC4 extracts (97% inhibition to Kb cells at 10 pg/mL) of 
anather cyclic depsipeptide, which we have named onchidin B 
(4) (Chart 3), and that shares with onchidin (2) a great number 
of structural features. 
Isolation and Structural Analysis 
Onchidizcm sp. (hlmonata, order: Stylommatophora, fam- 
ily: Onchidiidae) was collected at Chesterfield archipelago in 
the intertidal zone on “Ile Longue” (Mouillage isles, 450 NW 
of New Caledonia). 
Kb (human epidermoid carcinoma cells) bioactivity-guided 
isolation by solvent partition and further chromatography of the 
methanolic extract afforded 3 mg of pure onchidins (2) (p-388 
cells, ICs0 = 8 pg/mL) and 5 mg of onchidin B (4) [IC50 = 8 
pg/mL to Kb cells, [ c ~ ] ~ D  -220.1’ (c 0.1, CHC13)]. The (+) 
FABMS spectrum showed a molecular ion ,at m/z 1153, whose 
molecular formula C62H196N4016 (17 unsaturations) was deduced 
on the basis of its HRFABMS peak (m/z 1153.6999 [M + m+, 
A + 9.9 mmu). The edited DEFT and I3C NMR spectra showed 
the presence of 62 carbons. Among them, the following signals 
could be easily identiffied 10 amide or ester carbonyls (6 = 
175.4-166.3 ppm), 14 methyl signals (6 = 20.1-9.4 ppm), 2 
N-methyl signals (6 = 32.2 and 31.3 ppm), 10 methines, 
attached to oxygen or nitrogen (6 = 83.5-57.6 ppm), 2 
methylenes at 46.7 and 46.6 ppm, assigned as nitrogen-bearing 
carbons, and another 4 signals (6 = 83.9, 82.8, 68.9, and 68.6 
ppm) that were assigned to two terminal acetylenes (Table 1). 
The presence of two acetylene functional groups was confirmed 
by the presence of two high field methylene carbons at ¿ic 18.2 
The ‘H NMR (500 MHz, CDC13) showed as the most relevant 
resonances: ten methines, corresponding to the a-amino and 
&hydroxy acid protons at 6 = 5.34 (H-9), 5.26 @I-2), 5.14 
(H-16), 4.63 (H-51), and 4.18 (H-46) as well as two N-methyl 
singlets at 6 3.21 (MeVal 1) and 3.15 (MeVal 2). In addition, 
the two terminal acetylenic protons were detected as driplets 
(due to propargylic coupling), at b = 1.94 (H-14, t, J = 2.6 
The structure of 4 was determined by a detailed analysis of 
one- and two-dimensional NMR spectra. A combination of 
HMQC, COSY, TOCSY, and HMBC indicated the presence 
of ten independent spin systems: four amino acid units and six 
(9) Rodriguez, J.; Riguera, R; Debitus, C. J. Org. Chem 1992,57,4624- 
4632. 
(C-12) and 18.1 (C-42). 
(H-32), 5.09 (H-27), 5.Q8 (H-21), 4.90 (H-39),4.73 (H-57),4.66 
Hz) and 1.91 (EU-44, t, J = 2.6 Hz). 
Fernández et al. 
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Table 1. ‘H NMR and 13C NMR Data of Onchidin B (4) in 
CDCl3 
C no. ‘H, m (J in HzY 13Cb C no. ‘H, m (Jin H z ) ~  13Cb 
MeVal 1 MeVal 2 
1 171.9 31 173.2 
2 5.26, d (10.0) 59.6 32 5.14, d (10.0) 60.8 
3 2.15, m 28.2 33 2.19, m 29.3 
4 0.88, d (6.5) 19.5 34 0.96, d (7.0) 20.1 
5 1.01, d (7.0) 19.7 35 1.10, d (7.0) 19.9 
NMe 3.21,s 31.3 NMe 3.15, s 32.2 
Hymo 1 Hymo 2 
6 174.2 36 175.4 
8 1.07, d (6.5) 15.0 38 1.13, d (7.0) 14.4 
9 5.34, dddd (10.0; 75.3 39 4.90, dddd (10.0; 78.2 
7 3.10, dq (2.0;7.0) 40.0 37 3.15, m 39.5 
10.0;5.0;2.0) 10.0;5.0;2.0) 
ia 1.79, m 30.6 40 1.99, m 30.8 
11 1.58, m 23.5 41 1.67, m 23.2 
12 2.19, dddd (16.5; 18.2 42 2.22, dddd (16.5; 18.1 
13 83.9 43 82.8 
14 1.91, t (2.6) 68.6 44 1.94, t (2.6) 68.9 
pro 1 pro 2 
15 171.4 45 168.9c 
16 4.66, d (8.5) 57.6 46 4.18, d (9.0) 60.3 
17 2.12, m 31.5 47 2.15, m 28.4 
2.06, m 2.06, m 
18 1.84, m 26.2 48 1.84, m 20.6 
1.62, m 49 3.57, m 46.6 
19 3.58, m 46.7 3.48, m 
20 168.9 50 167.3c 
21 5.08, d (2.5) 77.2 51 4.63, d (11.5) 83.5 
22 2.02, m 35.0 52 1.69, m 34.0 
23 1.51, m 23.0 53 1.22, m 25.6 
24 0.90, t (7.0) 11.4 54 0.89, t (7.0) 9.4 
25 0.98, d (7.0) 15.8 55 0.91, d (7.0) 13.6 
Hiv 1 Hiv 2 
26 166.3 56 169.4 
27 5.09, d (3.5)i 77.3 57 4.73, d (8.5) 79.2 
28 2.38, xn 30.8 58 2.20, m 29.2 
291 0.95, d (7.0) 16.6 59 0.97, d (6.01 17.9 
1.46, m 1.54, m 
7.0;7.0;2.5) 7.0;7.0;2.5) 
HmP 1 HmP 2 
301 1.02, d ‘(7.0) 19.0 60 1.03, d (6.01 18.8 
a Assignments based on COSY rund TOCSY. Assignments based 
on HMQC and HMBC. “Assignments for these signals may be 
interchanged. 
hydroxy acid units (Figure 1). Badly overlapped protons were 
resolved by observing TOCSY correlations. The a-methine 
proton of substructure 4a 6 4.66 (H-16, Pro 1) was connected 
to a set of protons formed by H-17 (2.12/2.06), H-18 (1.84/ 
1.62), and H19 (3.58). In the same way, the signal at 6 4.18 
Oitchidin B 
4a 4b 
4c 4d 
4e 
Figure 1. Partial structures 4a-e and selected COSY correlations. 
(H-46, Pro 2) was connected to those of H-47 (2.15/2.06), H-48 
Two spin systems with N-methyl valine (MeVal), 4b, were 
depicted as follows: 'H NMX resonances at 6 5.26 (€3-2, MeVal 
1) showed COSY correlations to 2.15 (H-3) and this last signal 
to Me-4 and Me-5 (1.01 and 0.88, respectively). The same 
information was deduced from the following COSY correlation 
set: 5.14 (H-32, MeVal 2)/2.19 (H-33)/1.10-0.96 (Me-34, Me- 
35). One bond heteronuclear correlations allowed the identi- 
fication of a-carbons, [d 59.6 (MeVal 1, C-2) and 60.8 (MeVal 
2, C-32)] and ß-carbons [d 28.2 (MeVal 1, C-3) and 29.3 
(MeVal 2, C-33)] for both residues. HMBC correlations 
between the N-methyl signal at 3.21 and the a-carbon at 59.6 
(MeVal 1) and between the N-methyl at 3.15 and the a-carbon 
at 60.8 established unambiguously the presence of the N-methyl 
group in the Valines. 
Another two similar patterns of correlations were detected 
in the COSY and TOCSY spectra for the 2-hydroxyisovaleric 
acids (Hiv). Thus, the a-methine protons H-27 and H-57 [d 
5.09 (Hiv 1) and 4.73 (Hiv 2), respectively] were connected to 
another two methines [d 2.38 (H-28, Hiv 1) and 2.20 (H-58, 
Hiv 2)] bonded to two pairs of methyl groups [d 1.02/0.95 (Me- 
34/Me-35, Hiv l )  and 1.03/0.97 (Me-59/Me-60, Hiv 2)]. 
Nevertheless, the chemical shifts of the a-carbons obtained from 
HMQC [d 77.3 (Hiv 1) and 79.2 (Hiv 2)] were significatively 
downfield from those of the valines, allowing the unambiguous 
assignment of the signals for the two hydroxy acid units (4c). 
COSY and TOCSY for two additional spin systems showed 
the following pattern of correlations: in each case, an a-methine 
proton [d 5.08 (H-21, Hmp 1) and 4.63 (H-51, Hmp 2)] was 
connected to another methine [d 2.02 (H-22, Hmp 1) and 1.69 
(H-52, Hmp 2)]; this last methine was connected to both a 
methyl group [d 0.98 (€3-25, Hmp 1) and 0.91 (H-55, Hmp 2)] 
and a methylene group [d 1.51 (H-23, Hmp 1) and 1.22 (H-53, 
Hmp 2)]; findly, this methylene was connected to a second 
methyl group [d 0.90 (Hmp 1) and 0.89 (Hmp 2)]. HMQC 
spectrum allowed the assignment of the resonances of all the 
protonated carbons. The chemical shifts obtained for the 
a-carbons [d 77.2 (C-21, Hmp 1) and 83.5 (C-51, Hmp 211 were 
consistent with the presence of oxygen substituents. Thus, these 
(1.84), and H-49 (3.57/3.48). 
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Figure 2. Selected HMBC correlations of onchidin B (4). 
two spin systems belong to 2-hydroxy-3-methylpentanoic acid 
units, Hmp (4d). 
The remaining spin systems have the following connectivity 
pattern according to COSY, HMQC, and TOCSY analysis: each 
unit possessed a methine group lH/13C NMR [d 3.10140.0 (C- 
7, Hymo 1) and 3.1Y39.5 (C-37, Hymo 2)] connected to a 
methyl group [d 1.07/15.0 (C-8, Hymo 1) and 1.13/14.4 (C-38, 
Hymo 2)] as well as to an oxygen-bearing methine [d 5.34/ 
75.3 (C-9, Hymo 1) and 4.90/78.2 (C39, Hymo 2)] which is 
bonded to a chain formed by three methylenes, the last one being 
connected to a terminal acetylene [d 1.91/68,6 (C-14, Hymo 1) 
and 1.94/68.9 (C-44, Hymo 2)]. Further HMBC experiments 
reaffirmed the presence of the alkyne group: correlations from 
the signal at 2.19 ppm (H-12, Hymo 1) to carbons at 68.6 (C- 
14, Hymo 1) and 83.9 ppm (C-13, Hymo 1) and from the proton 
at 2.22 (H-42, Hymo 2) to carbons at 68.9 (C-44, Hymo 2) and 
82.8 ppm (C-43, Hymo 2). This connectivity pattern is exactly 
the same as we have already found in the ß-amino acid Amo 
(3), present in onchidin (2), but the chemical shift of the 
ß-carbons are notably downfield from those of Amo. All these 
data led us to identify these two spin systems (4e) as belonging 
to a new ß-hydroxy acid, 3-hydroxy-2-methyloct-7-ynoic acid, 
Hymo (5), that is reported for the first time in this work. 
Relevant information pertaining to the determination of the 
bonding sequence was carried out using 13C-lH long range 
correlation experiments (HMBC), assigning the connectivities 
from carbonyl carbons to the adjacent amino or hydroxy 
substituted Ca-H protons. In this way, the presence of the 
structural segment Hiv 2-MeVal 1-Hymo 1 was established by 
the following correlations (Figure 2): CO (C-56, Hiv 2)/H-57 
(Hiv 2); CO (C-1, MeVal 1)/H-57 (Hiv 2) and H-2 (MeVal 1); 
CO (C-6, Hymo 1)/H-2 (MeVal l), NMe (MeVal l), and Me-8 
(Hymo 1). Similarly, two other skeletal segments were deduced 
from the correlations shown next: CO (C-20, Hmp 1)/H-16 (Pro 
1) and H21 (Hmp 1) (segment Pro 1-Hmp l), and CO (C-31, 
MeVal 2)/H-27 (Hiv 1) and H-32 (MeVal 2); CO (C-36 Hymo 
2)/H-32 (MeVal 2), NMe (MeVal 2), and Me-38 (Hymo 2) 
(segment Hiv 1-MeVal 2-Hymo 2).1° 
The (+) FABMS of 4 showed, in addition to LM + HI+ peak 
at d z  1153, the parent ion peak at d z  577 (100%). HRFABMS 
provided a value of d z  577.3479 ([C31&8N208 + HI+, A - 
(10) HMBC shows also a strong correlation between C-26 (Hiv 1) and 
the multiplet at 6 = 5.08-5.09 ppm. This multiplet is produced by the 
overlapping of the H-21 (Hmp 1) and 827 (Hiv 1) resonances, and so, the 
connection between Hmp 1 and Hiv 1 could only be unambiguously 
established after MS and selective hydrolysis. 
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Figure 3. Onchidin B depsipeptide sequence determination by 
FABMSIMS. 
0.9 mmu) that corresponds to the cleavage of the molecule into 
halves with identical mass. In order to shed light on the 
sequence, we decided to cany out (MS)n experiments. Thus, 
collisionally induced tandem FABMS (FABMSIMS) of the d z  
577 [C31&sNzO8 + HI+ fragment gave ions at m/z 577 wo- 
Hmp-Hiv-MeVal-Hymo + H)+, m / ~  549 (Pro-Hmp-Hiv-MeVal- 
Hymo - do -I- H)f, d z  480 (Hmp-Hiv-MeVal-Hymo 4- H)+, 
d z  464 (Hymo-Pro-Hmp-Hiv + H)f, m/z 463 (Hiv-MeVal- 
Hymo-Pro + H)+, d z  397 (Pro-Hmp-Hiv-MeVal - CO + H)+, 
m/z 366 (Hiv-MeVal-Hymo + H)+, m/z 312 (Pro-Hmp-Hiv -I- 
H)+, m/z 284 (Pro-Hmp-Hiv - CO +H)+, d' 266 (MeVal- 
Hymo 4- H)+, d z  215 (Hmp-Hiv + H)t, and m/z 184 (Pro- 
Hmp - CO + H)+ (Figure 3) whose assignment corroborates 
the NMR results and completes the linkages between the 
structural units, suggesting that onchidin B is composed by the 
sequence Pro-Hmp-Wiv-MeVal-Hymo-Pro-Hmp-Hiv-MeVal- 
Hymo. This accounts for only 16 unsaturation degrees and, 
therefore, to satisfy the molecular formula requirements (17 
unsaturations), 4 must have the ccorresponding cyclic structure. 
Stereochemistry of Onchidin B 
Information about the absolute stereochemistry of onchidin 
B and additional evidence of its structure was achieved by GC- 
MS analysis of its components. Hydrolysis of 4 with 6 M HC1 
(110 OC, 24 h) followed by derivatization and GC-MS analysis 
on a chiral column (Chirasil-Val EL) revealed the presence of 
(S)-Hiv, (S,S)-Hmp, (R)-MeVal, (S)-Pro, and (R)-Pro in a 22:  
2:l:l ratio. 
Furthermore, smooth basic hydrolysis (1 M NaOWMeOH) 
of 4 cleaves the ester bonds and affords, after treatment with 
diazomethane, the expected three dipeptides (Figure 4): (S,S)- 
Hmp-(S)-Pro-OMe (6), (S,S)-Hmp-(R)-Pro-OMe (7), and Hymo- 
(R)-MeVal-OMe (8). 6 and 7 were identified by comparison 
(GC-MS) with authentic samples, unambiguously confirming 
the presence of both (S)-Pro and (R)-Pro in onchidin B (4). A 
third component (8) from the mixture was identified by EIMS 
proving the location of Hymo next to MeVal as previously 
suggested by NMR. 
At this stage, the only remaining point to be solved was the 
absolute configuration of the two asymmetric centers of the 
ß-hydroxy acid Hymo. No useful J values could be obtained 
due to massive overlapping in the 'H NMR spectrum. A strong 
NOE was detected between l3-7LH-9 and H-37/H-39, but it was 
not conclusive to distinguish between eritro or threo relative 
stereochemistries. To overcome this difficulty, we decided to 
prepare the four stereoisomers of Hymo and proceed to their 
Fenuindez 
4 
1) NaOH I N  
2) CHzNz I 
et al. 
(S,S)-Hmp(SpPro-OMe (63 (S,SpHmp-(R)-Pro-OMe (7) 
+ 
(R,R)-Hymo-(R)-MeVal-OMe (8)
Figure 4. Basic hydrolysis of onchidin B (4). 
comparison with the natural one, obtained by hydrolysis of 
onchidin B (4). 
Diasteroselective Synthesis of Hymo 
All four possible stereoisomers of 3-hydroxy-2-methyloct- 
7-ynoic acid (5) were synthesized in a diastereosellective mode. 
The synthetic strategy relies on the well-known reaction 
developed by Evans et aL," between the enolborinate of 
optically pure N-propionyl oxazolidinones and aldehydes to 
obtain enantiomerically pure aldols and on the Mitsunobu 
reaction12 which allows the inversion of configuration at the 
hydroxylated carbon of the aldol, yielding its epimer. 
Reaction of N-propionyl oxazolidinone 9a, derived from (SI- 
phenylalanin~l,'~ with hex-5-ynal (prepared from hex-5-yn-l- 
01 by a Swern oxidation)14 gives the aldol 10 with configuration 
(2S, 3R), whereas the reaction of oxazolidinone 9b, obtained 
from ( 1S,2R)-norephedrineY with the same aldehyde provides 
aldol 11 with configuration (2RY3S). 
Compounds 10 and 11 were obtained optically pure when 
the reactions were carried out with freshly opened bottles of 
dibutylborontriflate, since no other diastereomers were detected 
by NIMR. Standard hydrolysis15 of 10 and 11, followed by 
diazamethane treatment, afforded ß-hydroxy methyl esters 12b 
(2S,3R) and 13b (2R,3S), respectively. 
In order to prepare the other two stereoisomers (2RY3R and 
2S,3S), the inversion of one of the chiral centers of both 10 
(11) Evans. D. A.:Barkoli. J.: Shih. T. L. J. Am Chem Soc. 1981.103, , ,  . 
21i7:2129. ' 
React. 1992,42, 335-656. 
(129 (a) Mitsunobu, O. Synthesis 1981, 1-28. @) Hugues, D. L. Org. 
(13) Gage, J. R.; Evans, D. A. Org. Synfh. 1989, 68, 77-91. 
(14) Freeman, F.; Kim, D. S. H. L.; Rodriguez, E. J. Org. Chem. 1992, 
57, 1722-1727. 
(15) Evans. D. A.: Britton. T. C.: Ellman, J. A. Tetrahedron Lett. 1987, 
28,'6741-61&. ' 
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12b 
13b 
"(a) (nBu)zBOTf, Et3N, CHzC12, O OC and then hex-5-ynal, CH;?Clz, -70 OC; (b) LiOH, HzOZ, THF-HzO, O OC; (c) CHzNz, EtzO; (d) 
diethylazodicarboxylate, triphenylphosphine, p-nitrobenzoic acid, benzene; (e) 30% HzOZ, LiOH, O OC. 
and 11 was needed. Since the configuration at position 2 could 
not be fully inverted easily, we decided to concentrate our efforts 
on the inversion of the configuration at carbon 3 making use of 
the Mitsunobu reaction. When ß-hydroxy methyl ester 12b was 
submitted to Mitsunobu conditions, no successful results were 
obtained. Nevertheless, a smooth inversion took place when 
aldols 10 and 11 were treated in similar conditions16 and 
p-nitrobenzoate esters 14 and 15 were obtained in good yields. 
Simultaneous hydrolysis of the benzoate ester and oxazolidinone 
moieties, followed by diazomethane treatment, afforded the 
desired (2SSgS)-ß-hydroxy methyl ester 16 and its (2R,3R) 
isomer 17, in good yields. 
Direct comparison of the methyl esters of the four synthetic 
stereoisomers with the methyl ester of Hymo, the natural 
component of onchidin B (4), by chiral GC and HPLC was not 
successful in spite of our efforts to find experimental conditions 
suitable for a good separation of the four isomers. This problem 
was finally overcome by HPLC-MS analysis of the 3-O-[(-)- 
(R)-a-methoxy-a-(9-anthryl)acetyl]-2-methyloct-7-ynoic methyl 
esters (18-21). These derivatives were prepared by standard 
treatment of the hydroxy esters with (-)-(R)-a-methoxy-c(9- 
anthry1)acetic acid,17 and were chosen because they provide four 
beautifully separated peaks in the HPLC chromatogram. In 
addition, they present strong and characteristic UV absorption 
and give clean CIMS fragmentations that enabled a safe 
comparison by coinjection with the natural Hymo. 
Thus, reaction of the four synthetic ß-hydroxy esters with 
(-)-(R)-a-methoxy-a-(9-anthryl)acetic acid, in the presence of 
DCC and DMAP, afforded the corresponding derivatives that 
showed the following retention times in HPLC-MS with the 
mass detector fixed at m/z 378: (S,R) 28.09 min, (R,R) 30.93 
min, (R,S) 41.74 min, and (S,S) 46.54 min. 
(16) Soie, H.; Kondo, T.; IGryu, M.; Ishiwata, H.; Ojika, M.; Yamada, 
(17) Latypov, Sh. K.; Seco, J. M.; Quiiíoá, E.; Ripera, R. J. Org. Chem. 
K. J. Org. Chem. 1995,60, 4774-4781. 
1995,60, 504-515. 
Chart 2 
5 18 (2.535) 
19 (2R,3R) 
20 (2S,3R) 
21 (2R,3S) 
Onchidin B (4) was hydrolyzed with 6 M HCI at 110 "C for 
24 h, and the mixture containing the free Hymo was esterified 
first with diazomethane and then with (-)-(R)-a-methoxy-a- 
(9-anthry1)acetic acid. HPLC-MS of that mixture showed a peak 
with identical tR, UV, and MS as isomer (2R,3R)-3-0-[(-)- 
(R)-~-methoxy-a-(9-anthryl)acetyl]-2-methyloct-7-ynoic methyl 
ester. Therefore, the absolute configuration of the natural Hymo 
(5) is (2R,3R) and the structure of onchidin B (4) is cyclo [(R)- 
MeVal-(R,R)-Hymo-(S)-Pr~(S,S)-~p-(S)-H- 
Finally, in order to assign the (R) and (S) stereochemistries 
to the prolines, characteristic 13C chemical shifts differenced8 
and additional NOES were considered. The linkage between 
Pro 1 and Hmp 1 is probably trans, as suggested by the value 
obtained for Ads, = 5.3 ppm for C-17 and C-18, while the 
bond between Pro 2 and Hmp 2 is probably cis in accordance 
with the value Adp, = 7.8 ppm for C-47 and C-48. A ROESY 
correlation between H-21 (Hmp 1) and H-19 (Pro 1) confirms 
the trans assignment for Pro l.19 These considerations, together 
with the NOE observed between H-21 (Hmp 1) and H-16 (Pro 
1):O suggest that both hydrogens lie on the same side, so C-16 
Hymo-(R)-Pro-(S, S)-€hp-(S)-Hiv]. 
(18) Siexnion, I. Z.; Wieland, T.; Pook, K.-H. Angew. Chem, Int. Ed 
Engl. 1975,14, 702-703. 
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increment. FABMS were obtained on a Kratos MS-50 (employing Xe 
atoms at 7-9 KeV; glycerol and 2-hydroxyethyl disulfide + NaCl 
matrix) and FINIGAN 4000 (NBA matrix). Collisionally induced 
tandem mass spectra (MSMS) in the FAB mode were obtained on a 
four sector tandem mass spectrometer VG 70-SE4F. EMS was 
obtained on a Hewlett-Packard HP59970 spectrometer. 
HPLC separations were performed on a Waters Model 6000A using 
reversed-phase p-Bondapack C18 (7.8 mm I.D. x 30 cm) and p-porasil 
(7.8 mm I.D. x 30 cm). Gas chromatography analyses were performed 
using a Hewlett-Packard spectrometer with a Chirasil-Val III capillary 
column (50 m x 0.25 mm). 
Cytotoxic activity was assessed in vitro using Kb cells.% 
(lS,2R)-Norephedrine, ($)-phenylalanine, hex-5-yn-1-01, and dibu- 
tylboron triflate were purchased from Aldrich Chemical Company and 
were used without further purifcation. All solvents were distilled under 
argon utilizing standard literatnke procedures. Flash column chroma- 
tography was performed using Kieselgel 60 230-400 mesh Sioz gel 
into glass columns. Synthetic roducts were purified by HPLC before 
optical rotation measurements. Synthetic yields were not optimized. 
Extraction and Isolation. nimal Collection. Onchidium sp. is 
in July 1988 from Chesterfield archipelago in the intertidal zone on 
‘‘ne Longue” (Mouillage isles, 450 NW of New Caledonia), sample 
reference MG 332. Each &al weight was 300 g approximately. A 
voucher specimen is in deposit at the Museum National d’Histoire 
Naturelle in Paris, and it has been identified by Dr. Philippe Bouchet. 
Extraction and Partitioning. Three kilograms of mollusc were 
freeze-dried (600 g dry weight) and then extracted with methanol (4 
x 2 L). The methanol extract was decanted off and concentrated in 
vacuum. The viscous concentrate was partitioned between 400 mL of 
10% aqueous methanol and hexanes (2 x 400 mL). The methanolic 
portion was made 20% aqueous and extracted with CCh (2 x 400 mL). 
Then the methanolic portion was made 40% aqueous and extracted 
with CHzClz (3 x 400 mL). The organic layers were concentrated in 
vacuum to yield 2.9 g of hexane extract (15% inhibition to Kb cells at 
10 pg/mL), 1.2 g of CCL extract (97% inhibition to Kb cells at 10 
pg/mL), and 0.7 g of CHZClz e tract (99% inhibitioIv to Kb cells at 10 
The CC4 extract was subj ted to flash silica gel! column chroma- 
tography (3 x 20 cm, silica el 60, Merck 70-230 mesh) stepped 
gradient elution from 100% dio @I loromethane to 100% methanol giving 
five fractions: F1 (inactive), F2 (cytotoxic to Kb cells at 10 yglmL. 
93% inhibition), F3 (inactive), F4 (cytotoxic to Kb cells at 10 pg/mL: 
95% inhibition), and F5 (inactive). 
Isolation of Onchidin B. Fraction F2 was purified on a reversed- 
phasep-Bondapack C18 HPLC column (30 cm x 7.8 mm, 93:7 MeOH: 
HzO; flow rate: 2.0 “in) affording 5 mg (17 x % from the 
CCk extract) of onchidin B (4), t R  12.7 min; [a]$ -220.1’ (c 0.1, 
CHCI,); RIR (KBr) 3280,2980,2940,2880, 1747,1650,1640 cm-’; 
HRFABMS calcd for C&?H97N4016 d z  1153.6899 + HI+, found 
1153.6999, A f 9.9 mmu; HRFABMS calcd for c31&9N208 d z  
577.3488 N f HI+, found 577.3479, A - 0.9 “U; (+) FABMS 
@BA matrix): d z  (% relative intensity): 1153 [M + HI+ (7), 577 
(100). (f) FABMS (2-hydroxyethyl disulfide + NaCl matrix), d z  
(% relative intensity): 1175 [M 3- Na]+ (l), 1153 + HI+ (3,577 
(100). ‘H and 13C NMR see Table 1. 
Amino Acid Analysis by Chiral GC-MS. Onchidin B (4) (1 mg) 
was submitted to hydrolysis ith 6 M HC1 (0.5 mL) in a sealed tube 
at 1 U0 OC for 24 h. The exces HC1 was removed by passing a stream 
of Nz, and the residue was dri under vacuum. The hydrolyzates were 
diluted with water (1 mL), an the hydroxy acids were extracted with 
diethyl ether (3 x 1 mL). 
The ethereal solution was ‘ed under vacuum, and the residue was 
dissolved in 1 mL of ether and treated with diazomethane for 30 min. 
The excess of reagent was removed with a stream of dry Nz. Capillary 
a Puhonata, order: Stylomma I4 ophora, family: Onchidiidae, collected 
PdmL). 
li 
Chart 3 
Hmp 2 Hiv 2 MeVal 1 
14 
Hymo 1 
* 
MeVa/Z Hiv 1 Hmp 1 
4 
and C-21 must have identical configuration anrd Pro 1 should 
be (S). Furthermore, the lack of NOE between H-46 (Pro 2) 
and H-51 (Hmp 2), in spite of the cis stereochemistry, suggests 
that both protons do not lie on the same side of the molecule, 
and so the absolute configuration of Pro 2 should be (R). 
Onchidin B (4) is then a cyclic depsipeptide formed by the 
head-to-tail bonding of two chains (MeVal-Hymo-Pro-Hmp- 
Hiv) with identical sequence. In spite of this common sequence, 
onchidin B (4) has no Cz symmetry and shows signals for all 
the 62 carbons in the NMR spectra. This lack of coincidence 
of NMR signals is related to the presence of the two enantiomers 
of proline that renders the two halves of the molecule different. 
Similar structural characteristics were found in onchidin (2), 
the other cyclodepsipeptide isolated from this organism, but, 
in that case, the repeating amino and hydroxy acids have the 
same configuration and so compound (2) has C2 symmetry and 
presents only half the expected proton and carbon resonances. 
A further point of interest is the presence in onchidin B (4) 
and onchidin (2) of the obviously related acetylenic ß-hydroxy 
and /3-amino acids, [Hymo (5) and Amo (3)], respectively. A 
ß-hydroxy acid with the same skeleton but an additional methyl 
group at C-2 has recently been described by P. Scheuer as a 
component of the cyclodepsipeptide kulolide isolated from the 
mollusc Philinopsis speciosa?l Another related molecule is  the 
ß-hydroxy acid, (2R,3S;I-7,7-dichloro-3-hydr~xy-2-methyloc- 
tanoic acid, isolated from the marine sea hare Dolabella 
that can be viewed as the dichlorinateld derivative 
of a Hymo stereoisomer. 
Experimental Section 
General Methods. IR and W spectra were obtained on MIDAC 
Prospect FI’lR and 8452 A spectrophotometers, respectively, and optical 
rotations on a Jasco DIP-370 digital polarimeter. NMR spectra were 
recorded on Bruker AMX 500, Bruker AMX 300, or Bruker WM 250 
spectrometers using CDCl3 as solvent and internal standard. The ‘H- 
‘H COSY spectrum was acquired with 4K x 354 matrix and eight 
scans per increment. The TOCSY spectrum was acquired with 4K x 
300 matrix and 16 scans per increment. The ROESY spectnun was 
acquired with 2K x 200 matrix and 32 scans per increment. The 
TOCSY and ROESY experiments were recorded using a mixing h e  
of 0.070 and 0.280 ms, respectively. The HMQCZ and HMBC’ 
sequences were penfomed with 2K x 200 matrix and 64 scans per 
(19) Masashi, T.; Shigemori, H.; Mikami, Y.; Kobayahi, J. Tetrahedron 
1993,49, 6785-6796. 
(20) According to the literature, NOEs between H-16 and H-21 should 
be expected if the linkage Pm 1-Hmp 1 were cis and between H-19 and 
8 2 1  if trans. Models indicate that in 4 both NOEs are possible depending 
on the flexibility of the molecule and, in fact, we have observed them 
experimentally. 
(21) Nakao, Y.; Juagdan, E. G.; Yoshida, W. Y.; Scheuer, P. J. Eighth 
International Symposium On Marine Natural Products; Santa Cruz de 
Tenerife, Canary Islands, September 10-15,1995. 
(22)Bax, A.; Subramanian, S. J. Am. Chem Soc. 1985, 107, 2820- 
2821. 
(23)Bax, A.; Summers, M. F. J. Am. Chem Soc. 1986, 108, 2093- 
2094. 
(24) Bergeron, R. J.; Cavanaugh, P. F., Jr.; Kline, S. J.; Hughes, R. G., 
Jr.; Elliot, G. T.; Porter, C.  W. Biochem Biophys. Res. Comm. 1984,121 
(3), 848-854.. 
(25) McDermott, J. R; Benoiton, N. L. Can. J. Chem. 1973,51,1915- 
1919. 
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GC-MS analysis were carried out using a Chirasil-Val III column (50 
m x 0.25 mm; carrier gas: He; flow rate: 1 " i n ;  column 
temperature: 50 OC, 60 min isothermal) to show peaks at t~ 15.39 and 
(S,R)-Hmp were also converted to the methyl derivatives by the same 
procedure. Retention times (minutes) were as follows: 15.51 [(S)- 
Hiv], 16.18 [(I?)-Hiv], 31.10 [(S,R)-Hmp], 32.50 [(R,S)-Hmpl, 33.69 
The water solution was dried under vacuum, and the resulting residue 
was divided into two equal portions. One of them was dissolved in 
dichloromethane (0.5 mL) and N-isopropyl isocyanate (1 mL) was 
added in a screwed-cap vial. After 60 min at 100 "C the excess of 
reagent was removed with a steady stream of dry Nz. Capillary GC- 
MS analysis were carried out using a Chirasil-Val III column (50 m x 
0.25 mm; carrier gas: He; flow rate: 1 &min; column temperature 
150 OC, 45 min isothermal, then programmed an increase of 5 "C/min 
to 200 OC) to show peak at t~ 33.11 min. Standards (5')- and (R)- 
MeVal [available by methylation of (3- and (R)-Val]25 were also 
converted to the N-isopropyl isocyanates by the same procedure. 
Retention times (min) were as follows: 31.02 and 33.30 for (9- and 
(R)-N-methyl valine, respectively. 
The second portion was dissolved in n-BuOH (0.5 mL) and HCl(3 
M, 0.5 mL) and heated in a sealed tube at 100 OC for 30 min. The 
product was evaporated, dissolved in trifluoracetic anhydride (0.5 mL) 
and CHZClz (0.5 mL), reacted in a sealed tube at 150 OC for 10 min 
and evaporated in a stream of nitrogen. Capillary GC-MS analysis 
were carried out using the same column Chirasil-Val III column (50 
m x 0.25 mm; carrier gas: He; flow rate: 1 " i n ;  cofumn 
temperature 50 OC, 30 min isothermal then programmed an increase 
of 2 "clmin to 200 Oc) to show peaks at tR 60.24 and 60.42 min. 
Standard (5')- and (R)-Pro were also derivatized by the same procedure. 
Retention times (min) were as follows: 60.36 and 60.55 for (R)- and 
(5')-proline, respectively. 
Alkaline Hydrolysis of Onchidin B. Onchidin B (4) (0.5 mg) in 
MeOH (0.5 mL) was treated under an argon atmosphere with NaOH 
(1 M, 0.5 mL) at O OC. After 1 h the reaction mixture was diluted 
with CHzClz (2 mL) and water (1 mL). The aqueous phase was 
acidified to pH 2 with 1 M HC1 and extracted with CHZC12 (2 x 2 
mL). The CHZC12 extract was dried with anhydrous NazS04 and 
concentrated in vacuum. The residue dissolved in ether (1 mL) was 
treated with an excess CHzNz at room temperature for 30 min, and the 
excess of reagent was removed with a steady stream of dry Nz. 
Capillary GC-MS analysis were carried out using a Chirasil-Val III 
column (50 m x 0.25 mm; He as carrier gas; flow rate 1 "in; 
column temperature 150 OC, 45 min isothermal then programmed at 5 
OMe EIMS d z  (% relative intensity): 211 (6), 155 (74), 127 (23)]; 
63.97 min [(S,s)-Hmp-(s)-Pro-OMe EIMS d z  (% relative intensity): 
211 (l), 155 (99), 127 (30)] and 69.37 min [(Hymo-MeVal-OMe EIMS 
d z  (% relative intensity): 267 (l), 238 (20), 230 (20), 201 (4), 144 
(19), 86 (loo)]. 
( ~ ~ ' s ~ ' R ) - 3 - ( 3 ' - H y ~ o ~ - 2 ' - m e U l y l - 7 ' ~ ~ o y l ) ~ ~ h ~ y ~ e U l y l ) -  
2-oxazolidmone (10). A stirred solution of N-propionyloxazolidinone 
9a (3.0 g, 12.9 "01) in dry dichloromethane (30 mL) was cooled to 
O OC and sequentially treated dropwise via syringe with 1 M dibutyl- 
boron triflate (18.0 mL, 18.0 mmol in dichloromethane) and triethyl- 
amine (3.0 mL, 2.2 g, 21.8 m o l ) .  The resulting solution was cooled 
to -70 OC, and a solution of hex-5-ynal (1.9 g) in dichloromethane 
(10 mL) was added dropwise via syringe. The resulting mixture was 
stirred at -60 OC for 20 min and then an additional hour at O OC. The 
reaction was quenched by addition of aqueous phosphate buffered 
solution (pH 7, 15 mL) and methanol (15 mL). Then a mixture 
methanol:30% HzOz (2:1,20 mL) was added, and the resulting solution 
was st i~ed for 45 min at room temperature. The solvent was evaporated 
under reduced pressure, the residue was redissolved in water (40 mL), 
and the resulting solution was extracted with EtOAc (3 x 20 mL). 
The combined organic phase was washed with 5% NaHC03 (40 mL) 
and brine (40 mL), dried over anhydrous MgSO4, and concentrated 
under reduced pressure, yielding a viscous yellow oil. The crude was 
purified by flash chromatography (Et0Ac:hexanes 1:3) and the aldol 
10 was obtained as a colorless viscous oil (3.4 g, 80% yield). [alD= 
f29.3" (c 1.2, CHC13). EIMS d z  (% relative intensity): 329 (M+, 
33.50 min. Standards (3- and (R)-Hiv and (S,S)-, (R,S)-, (R,R)- and 
[(S,S')-Hmp], and 35.25 [(R,R)-Hmp]. 
"C/min t0 200 O c )  t0 Show peaks at tR 62.86 min [(S,S)-kp-(R)-hO- 
2), 296 (lo), 244 (20), 233 (42), 196 (30), 178 (46), 153 (14), 148 
(17), 134 (82), 91 (loo), 85 (71), 57 (25). HREIMS: calcd for 
3289,2940,2872, 1777,1691, 1453,1386,1213, 1107,972 cm-'. 'H 
(m, 4 H), 1.90 (t, J = 2.3 Hz, 1 H), 2.17-2.25 (m, 2 H), 2.74 (dd, J 
= 13.3, 9.4 Hz, 1 H), 2.91 (s broad, 1 H), 3.20 (dd, J = 13.3, 3.3 Hz, 
1 H), 3.70 (m, 1 H), 3.93 (m, 1 H), 4.11-4.23 (m, 2 H), 4.65 (m, 1 
H), 7.14-7.35 (m, 5 H). 13C NMR (62.89 MHz,  CDC13): 6 10.3 (c), 
18.1 (t), 24.8 (t), 32.6 (t), 37.7 (t), 42.1 (d), 55.0 (d), 66.1 (t), 68.5 (s), 
70.9 (d), 84.1 (d), 127.4 (d), 129.0 (d), 129.4 (d), 135.0 (s), 153.0 (s), 
177.5 (s). 
(~,5~,2'~,3'~)-3-(3'-Hy~o~2'-methyl-7'-oc~oyl)-5-phenyl-4- 
methyl-2-oxazolidinone (11). Using the method described for the 
preparation of (4S,2'S,3'R)-3-(3'-hydroxy-2'-methyl-7'-~tynoyl)~-@h~ 
nylmethyl)-2-oxazolidinone (lo), N-propionyl oxazolidinone 9b (3.875 
g, 16.63 "01) was treated with 1 M dibutylborontriflate (18.3 mL, 
18.3 "01) and triethylamine (3 mL, 21.62 "01) and the resulting 
enolborinate was allowed to react with hex-5-ynal(2.1 g). After workup 
and purification the aldol 11 was obtained as a white solid (mp 97- 
100 OC), (4.1 g, 75% yield). [ a ] ~ ~  $8.3 (c 1.6, CHC13). EIMS d z  
(% relative intensity): 262 (M+, 9), 234 (15), 233 (loo), 178 (20), 
134 (36), 188 (42), 107 (60), 91 (21), 57 (25). HREIMS: calcd for 
3292,2940,2875,1779,1694,1455,1351,1231,1197,1120,960 cm-'. 
J = 6.9 Hz, 3 H), 1.54-1.79 (m, 4 H), 1.96 (t, J = 2.3 Hz, 1 H), 
2.22-2.27 (m, 2 H), 2.78 (s broad, 1 H), 3.78 (m, 1 H), 4.00 (m, 1 H), 
4.80 (m, 1 H), 5.69 (d, J = 7.3 Hz, 1 H), 7.26-7.46 (m, 5 H). I3C 
33.1 (t), 42.6 (d), 55.1 (d), 69.0 (s), 71.4 (d), 79.3 (d), 84.5 (d), 126.0 
(d), 129.1 (d), 129.2 (d), 133.4 (s), 153.0 (s),7!77.7 (s). 
Methyl (2S,3R)-3-Hydroxy-2-methyl-7-octy&oate (12b). A solu- 
tion of the aldol 10 (1.24 g, 3.76 "01) in THF:H20 (4:1,20 mL) was 
cooled to O "C. To this solution were sequentially added 30% HZOZ 
(1.53 mL, 15.04 "01) and a solution of LiOH (252 mg, 6.0 mmol) in 
water (5 d). The solution was stirred for 1 h. A solution of NazS03 
(1.89 g, 15.04 "01) in water (12 mL) was added, and the resulting 
solution was stirred for another 15 min. The organic solvent was 
concentrated under reduced pressure, and the resulting aqueous phase 
@H 12) was extracted with dichloromethane (3 x 40 mL). Then the 
aqueous phase was cooled to O OC, acidified to pH 1 with 1.5 M HC1, 
and extracted with EtOAc (5 x 40 mL). The organic phase was dried 
over anhydrous MgS04, filtered, and concentrated under reduced 
pressure. The j3-hydroxy acid 12a was obtained as a viscous colorless 
oil  (610 mg, 95% yield). The dichloromethane extract was dried over 
MgS04 and filtered, and the solvent was removed under reduced 
pressure. In this way the chiral oxazolidinone auxiliary was recovered 
as a white solid (565 mg, 85% yield). [ a ] ~ ~  -1-6.2 (c 2.0, CHC13). 
EIMS d z  (% relative intensity): 170 (M+, l), 137 (4), 124 (4), 103 
(35), 85 (43), 74 (loo), 57 (21). HREIMS: calcd for C9H1403 d z  
1709, 1456, 1408, 1210, 1078, 958 cm-'. 'H NMR (300.13 MHz, 
CDCl3): 6 1.20 (d, J = 7.2 Hz, 3 H), 1.52-1.79 (m, 4 H), 1.96 (t, J 
= 2.6 Hz, 1 H), 2.21-2.26 (m, 2 H), 2.59 (dd, J = 7.2, 3.3 Hz, 1 H), 
3.98 (m, 1 H), 6.51 (s broad, 2 H). I3C NMR (75.47 MHz,  CDC13): 
6 10.7 (c), 18.6 (t), 25.2 (t), 32.9 (t), 44.6 (d), 69.1 (d), 71.6 (s), 84.4 
(d), 181.4 (s). 
N-Nitroso-N-methyl urea (150 mg) was added to a two-phase 50% 
aqueous K0H:ether system (30 mL, 1:2), When the gas evolution 
ceased, the organic phase was carefdly decanted and added to a solution 
of the /3-hydroxy acid 12a (57 mg, 0.33 m o l )  in ether (10 mL) at 
room temperature. After 30 min the solvent was evaporated with an 
argon flow, yielding the j3-hydroxy methyl ester 12b as a yellowish 
oil. [ a ] ~ ~  f14.3 (c 0.4, CHC13). (+) FABMS (glycerol matrix) d z  
(% relative intensity): 185 M 4- H]+ (89), 167 (15), 153 (35), 125 
(l l) ,  107 (78). HREIMS: calcd for C1oH1603 d z  184.1099 (M'), 
1434, 1368, 1264, 1201, 1167, 1087, 1046 cm-'. 'H NMR (300.13 
MHz,CDC13): 61.19(d,J=7.2Hz,3H),1.51-1.64(m,3H),1.70- 
1.80 (m, 1 H), 1.95 (t, J =  2.6 Hz, lH), 2.23 (m, 2 H), 2.51-2.59 (dq, 
J = 7.2, 3.5, 1 H), 3.71 (s, 3 H), 3.91 (m, 1 H). 13C NMR (62.89 
C19H230& d z  329.1627 (M'), found 329.1629. FTIR (CHC13): 3526, 
NMR (250.13 MHz, CDC13): 6 1.22 (d, J = 7.1 Hz, 3 H), 1.47-1.75 
c19H23No4 d z  329.1627 (M+) found 329.1630. FTJR (CHCl3): 3521, 
'H NMR (300.13 MHz, CDCl3): 6 0.89 (d, J =  6.6 Hz, 3 H), 1.25 (d, 
NMR (75.45 MHz, CDC13): 6 10.6 (c), 14.7 (c), 18.6 (t), 25.3 (t), 
170.0942 (M') found 170.0937. FTIR (CHC13) 3453, 3292, 2943, 
found 184.1099. FTIR (CHC13) 3507-3465,3294,2946,1728,1448, 
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MHZ,  CDC13): 6 10.6 (c), 18.1 (t), 24.8 (t), 32.7 (t), 44.3 (d), 51.7 (c), 
68.6 (d), 71.3 (d), 84.1 (s), 176.5 (s). 
Methyl (zRY3S)-3-Hydroxy-2-methyl-7-octynoate (13b). Aldol 11 
was hydrolyzed using the method described for the hydrolysis of 10. 
Thus, aldol 11 (888 mg, 2.7 "01) was treated with 30% HZOZ (1.1 
mL, 10.84 "01) and LiOH (182 mg, 4.3 "01). After workup and 
purification the chiral auxiliary oxazolidinone was recovered (425 mg, 
88% yield), and the /.?-hydroxy acid 13a was obtained as a colorless 
viscous oil (440 mg, 95% yield). [a]~~~ -6.0 (c 1.3, CHCl3). NMR 
and MS spectroscopic data are identical to those obtained for 12a. 
13b was obtained by treatment of /.?-hydroxy acid 13a with excess 
diazomethane as described previously for @-hydroxy methyl ester 12b. 
NMR spectroscopic data are identical to those obtained for 12b. [a]~~ 
-13.0 (c 0.7, CHCl3). (4) FABMS (glycerol matrix) d z  (% relative 
intensity): 185 +HI+ (93), 167 (23), 153 (41), 125 (18), 107 (71). 
HREIMS: calcd for C10H1603 m/z 184.1099 @ït), ffound 184.1099. 
1.61 (m, 2 H), 1.75 (m, 1 H), 1.95 I(t, J =  2.6 Hz, 1 H), 2.23 (m, 2 H), 
2.53-2.57 (m, 2 H), 3.71 (s, OMe, 3 H), 3.91 (m, 1 H). 13C NMR 
51.7 (c), 68.5 (d), 71.2 (d), 84.1 (s), 176.5 (s). 
(4s,2'~,3'S)-3-[2'-Methyl-Y-[(4''-~~obe~oyl)o~]-7y-octynoyl]- 
4-phenylmethyl-2-oxazolidinone (14). A solution of diethylazodi- 
carboxylate (1.48 g, 8.47 "01) in benzene (5 mL) was added to a 
solution of aldol 10 (400 mg, 1.21 mmol), triphenylphosphine (2.22 g, 
8.47 mmol), andp-nitrobenzoic acid (1.42 g, 8.47 "01) in benzene 
(40 mL) at room temperature. The resulting solution was stirred for 
17 h at room temperature. The solvent was removed under reduced 
pressure, and the reaction crude was purified by flash chromatography 
(Et0Ac:hexanes 1:7), yielding the nitrobenzoate ester 14 as a colorless 
viscous oil (500 mg, 86%). [ a ] ~ ~  +72.1 (c 0.4, CHC13). EIMS d z  
(% relative intensity): 478 (M+, 2), 382 (l), 327 (l), 311 (5), 302 
(ll), 296 (lo), 283 (2), 272 (4), 244 (27), 231 (3), 178 (5), 150 (loo), 
135 (51), 134 (22), 117 (22), 104 (28), 91 (38). HREILMS: calcd for 
2945, 1780, 1720, 1604, 1528, 1449, 1387, 1350, 1274, 1214, 1110, 
1020 cm-'. 'H NMR (300.13 MHz,  CDC13): 6 1.33 (d, J = 7.0 Hz, 
3 H), 1.66 (m, 2 H), 1.88 (m, 1 H), 1.95 (t, J =  2.6 Eh, 1 H), 2.05 (m, 
1 H), 2.26 (m, 2 H), 2.74 (dd, J = 13.3, 9.5 Hz, 1 H), 3.27 (dd, J = 
13.3,3.3 Hz, 1 H), 3.97 (t, J = 8.2 Hz, IH), 4.12 (dd, J =  9.1,2.6 Hz, 
1 H), 4.30 (dd, J = 8.6, 7.0 Hz, 1 H), 4.55 (m, 1 H), 5.55 (ddd, J = 
8.2, 8.2,3.2 Hz, 1 H), 7.14-7.17 (m, 2 H), 7.25-7.33 (m, 3 H), 8.16- 
8.20 (m, 2 H), 8.26-8.30 (m, 2 H). 13C NMR (75.47 MHz, CDC13): 
6 14.6 (c), 18.6 (t), 23.9 (t), 30.7 (t), 38.1 (t), 41.6 (d), 55.6 (d), 66.5 
(t), 69.5 (d), 76.3 (d), 83.9 (s), 124.0 (d), 127.9 (d), 129.4 (d), 129.8 
(d), 131.2 (d), 135.2 (s), 135.7 (s), 151.0 (s), 153.5 (s), 164.1 (s), 174.2 
6). 
(~~S~R~'~)-3-[3'-[(4"-Nitrobenzoyl)o~]-2'-methyl-7'-o~oyl]- 
5-phenyl-4-methyl-2-oxazolidinone (15). Aldol 11 (270 mg, 0.82 
"01) was treated with triphenylphosphine (1.5 g, 5.74 mmol), 
p-nitrobenzoic acid (960 mg, 5.74 mmol), and diethylazodicarboxylate 
(0.9 mL, 5.74 m o l )  in the manner described for the preparation of 
nitrobenzoate ester 14. After workup and purifcation ester 15 was 
obtained as an oil together with a small amount of another product 
which could not be separated by HPLC (350 mg, 90% yield). [alsD 
-8.4 (c 0.7, CHC13). EIMS d z  (% relative intensity): 478 (M+, l), 
382 (l), 311 (3), 302 (2), 272 (2), 244 (3), 178 (6), 150 (loo), 135 
(27), 134 (40), 118 (13), 104 (26), 91 (21). HREIMS: calcd for 
C26H26N207 d z  478.1740 (M'), found 478.1730. FTIR (CHCS) 3292, 
2942, 2869, 1781, 1720, 1611, 1526, 1453, 1348, 1274, 1233, 11198, 
1115,1078 cm-'. 'H NMR (300.13 MHz, CDC13): 61 0.85 (d, J = 6.6 
Hz, 3 H), 0.95 (d, J = 6.6 Hz, 3 H), 1.61-1.72 (m, 2 H), 1.84-1.95 
(m, 1 H), 1.95 (t, J = 2.7 Hz, 1 H), 2.00-2.08 (m, 1 H), 2.23-2.34 
(m, 2 H), 4.29 (d, J = 6.6 Hz, 1 H), 4.65 (q, J = 6.8 Hz, 1 H), 5.44 
(d, J =  7.3 Hz, 1 H), 5.55 (td, J =  8.6, 8.6, 3.3 Hz, 1 H), 7.20-7.31 
(m, 2 H), 7.35-7.42 (m, 3 H), 8.27-8.31 (m, 2 H), 8.26-8.30 (m, 2 
H). 13C NMR (75.47 MHz, CDC13): 6 14.5 (c), 18.6 (c), 23.9 (t), 
27.4 (t), 30.7 (t), 41.8 (d), 55.3 (d), 69,5 (d), 76.3 (d), 79.3 (d), 83.8 
(s), 124.0 (d), 125.9 (d), 129.2 (d), 131.2 (d), 133.3 (d), 135.8 (s), 137.6 
(s), 151.0 (s), 153.0 (s), 164.2 (s), 174.2 (s). 
Methyl (2S,3S)-3-Hydroxy-2-methyl-7-octynoate (16). A O OC 
cooled solution of nitrobenzoate ester 14 (414 mg, 0.86 "01) in THF: 
' 'H NMR (300.13 MHz, CDC13): 6 1.19 (d, J =  7.3 Hz, 3 H), 1.51- 
(62.89 MHz, CDCl3): 6 10.6 (c), 18.1 (t), 24.8 (t), 32.6 (t), 44.3 (d), 
C26H26N207 d z  478.1740 (M'), found 478.1745. FTIR (CHCL) 3291, 
F e d n d e z  et al. 
HztO (40 mL, 4:l) was sequentially treated with 30% HzOz (0.43 mL, 
3.78 "01) and a solution of LiOH (120 mg, 2.86 "01) in HzO (1 
mL). The mixture was stirred for 1 h at O OC and then for a period of 
18 h at room temperature. Aqueous 10% Na2SO3 solution (5 mL) was 
added, and the organic solvent was removed under reduced pressure. 
The resulting aqueous phase was extracted with &chloromethane (4 x 
30 mL), acidified to pH 1 with 6 M HC1, and reextracted with EtOAc 
(4 x 30 mL). The combined EtOAc extract was washed with brine 
(50 mL), dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure. The residue was redissolved in ether (15 mL) and 
was treated with an ethereal solution of diazomethane. The solvent 
was evaporated with an argon flow, and the crude was purified by flash 
chromatography (Et0Ac:hexanes 1:8), yielding the @-hydroxy methyl 
ester 16 as a colorless viscous oil (120 mg, 76%). [a]~~ $2.5 (c 0.5, 
CHC13). (+) FABMS (glycerol matrix) d z  (% relative intensity): 185 
[M f HIf (loo), 167 (6), 153 @O), 125 1(13), 107 (59). EIMS m/z 4% 
relative intensity): 173 (l), 151 (23,143 (2), 117 (56), 107 (7), 97 (9), 
88 (100). HRHMS calcd for 'c1&& m/z 184.1099 @I+), found 
H), 1.45-1.83 (m, 4 H), 1.94 (t, J = 2.6, 1 H), 2.22 (m, 2 H), 2.52 (9. 
J =  7.1, 1 H), 2.66 (d, J =  6.4, 1 H), 3.67 (m, 1 H), 3.70 (s, 3 H). 13C 
(d), 52.2 (c), 69.0 (d), 73.2 (d), 84.6 (s), 176.8 (s). 
Methyl 1(zR~~)-3-Hydroxy-~-methy~-7-oc~oate (17). Following 
the procedure described above for the preparation of @-hydroxy methyl 
ester 16, benzoate ester 15 (273 mg, 0.57 "01) was treated with 30% 
HZOZ (0.25 mL, 2.28 "01) and LiOH (76 mg, 1.8 "01). After 
workup, the mixture of acids was esterifïed with excess of diaz- 
omethane. Purification gave the /.?-hydroxy methyl ester 17 as a 
colorless viscous oil (77 mg, 74% yield). [ a ] ~ ~  -2.6 (c 0.5, CHCl3). 
(+) FABMS (glycerol matrix) d z  (% relative intensity): 185 [M + 
HI+ (74), 167 (5), 153 (20), 125 (7), 107 (44). EIMS d z  (% relative 
intensity): 173 (l), 151 (2), 143 (2), 117 (56), 107 (7), 97 (9), 88 (100). 
HREIIMS calcd for c1,~&03 d z  184.1099 @I+), found 184.1099. 'H 
(m,4H),1.94(t,J=2.6,1H),2.22(m,2H),2.52(q,J=7.O,lH), 
2.66 (d, J = 6.4, 1 H), 3.66 (m, 1 H), 3.70 (s, 3 H). 13C NMR (75.47 
69.0 (d), 73.2 (Ca), 84.6 (s), 176 8 (s). 
Preparation of 3-O-[(-)-(R)-a-Me~o~-a-(9-anthryl)ace~l]-2- 
methyloct-7-ynoic Methyl Esters 18-21. General. The esters 18- 
21 were prepared by treatment OF the corresponding /.?-hydroxy ester 
(3 mg) with (-)-(R)-a-methoxy-a-(9-anthryl)acetic acid (5 mg) in the 
presence a€ DCC (4 mg) and DMAP (catalytic) in CH2C12 at room 
temperature. After 12 h the solvent w,as evaporated, and the crude 
was sequentially purified by flash chromatography (CHzC12) and HPLC 
(mporasil, 30 cm x 7.8 mm; Ac0Et:hexane 7:93; flow rate: 2.0 mL/ 
min). 
(a) (2Sy3S)-3-O-[(-)-(R)-a-methoxy-a-(9-anthryl)ace~l]-2-me- 
thyloct-7-ynoic Methyl Ester (U). [aIDz -119.1 (c 0.2, CHC13). 
ELMS d z  (% relative intensity): 432 (M+, 16), 221 (loo), 206 (15), 
205 (Il), 178 (16). HREIMS calcd for C27H2805 d z  432.1936 (M+), 
found 432.1963. 'H NMR (300.13 MHz, CDCl3): 6 0.45 (m, 2 H), 
1.05 (d, J = 7.2, 3 H), 1.12 (m, 1 H), 1.29 (m, 1 H), 1.44 (m, 2 H), 
1.69 (t, J = 2.6, 1 H), 2.58, (9, J = 7.1, 1 H), 3.44 (s, 3 H), 3.59 (s, 
3 H), 5.09 (m, 1 H), 6.22 (s, 1 H), 7.44-7.56 (m, 4 H), 8.00-8.03 (m, 
2 H), 8.47-8.52 (m, 3 H). 13C NMR (75.47 MHz,  CDC13): 6 12.9 
(cl; 17.6 (n), 22.8 (t), 29.5 (t), 43.2 (a, 52.1 (c), 57.9 (c), 68.7 (d), 
75.1 (d), 77.3 (d), 83.7 (s), 124.7 (d), 125.5 (d), 126.9 (d), 127.6 as), 
129.5 (d), 129.6 (d), 130.9 (s), 131.8 (s), 171.1 (s), 174.0 (s). 
@) (zR,3R)-3-O-[(-)-(R)-a-Metho~~a-(9-anthryl)ace~l]-2-~e- 
thyloct-7-poicMethy1 Ester (19). [alDZ -87.6 (c 0.2, CHC13). E M S  
m/z (% relative intensity): 432 (M+, 23), 221 (loo), 206 (19), 205 
(16), 178 (i3). HFSLMS calcd for C27H28O5 d z  432.1936 (M+), found 
1.52-1.68 (m, 2 H), 1.95 (t, J =  2.6, 1 H), 2.19, (m, 2 H), 2.33 (q, J 
= 7.0, 1 H), 2.94 (s, 3 H), 3.42 (s, 3 H), 5.15 l(m, 1 H), 6.26 (s, 1 H), 
7.45-7.57 (m, 4 H), 8.00-8.03 (m, 2 H), 8.48-8.57 (m, 3 H). 13C 
NMR (75.47 MHz, CDC13): 6 11.8 (c), 18.4 (t), 24.4 (t), 29.6 (t), 42.7 
(d), 51.5 (c), 57.8 (c), 69.2 (d), 75.2 (d), 77.5 (d), 84.0 (s), 124.8 (d), 
125.4 (d), 126.9 (d), 127.5 (s), 129.5 (d), 129.6 (d), 130.9 (s), 131.8 
(s) 171.0 (s), 173.2 (s). 
184.1099. 'H NlMR (300.13 MHz, CDQ3): 6 1.21 (d, J = 7.2 Hz, 3 
NMR (75.47 MHZ,  CDC13): 6 14.7 (c), 18.6 (t], 24.8 (t), 33.9 (t), 45.6 
NMR (300.13 MHz, CDCl3): 6 1.21 (d, J =  7.2 Hz, 3 H), 1.48-1.80 
MHz, CDC13): 6 14.7 (c), 18.6 at), 24.8 I(t), 33.9 (t), 45.6 (d), 52.2 (c), 
432.1963. 'H NMR (300.13 M!&, CDC13): 61 0.42 (d, J = 7.1, 3 H), 
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Determination of Absolute Configuration of Hymo (5). Onchidin 
B (0.5 mg) was submitted to hydrolysis with 6 M HCl(O.5 A) in a 
sealed tube at 110 OC for 24 h. The excess HC1 was removed by passing 
a stream of Nz, and the residue was dried under vacuum. The 
hydrolyzates were diluted with water (1 nL), and the hydroxy acids 
were extracted with diethyl ether (3 x 1 mL). The ethereal solution 
was dried under vacuum, and the residue was dissolved in 1 mL of 
ether and treated with diazomethane for 30 min. The excess of reagent 
was removed with a stream of dry Nz. The hydroxy methyl ester was 
treated with (-)-(R)-a-methoxy-a-(9-anthxyl)acetic a id (0.5 mg), DCC 
(0.5 mg), and DMAP (catalytic) in CHzCb at room temperature. After 
12 h the solvent was evaporated, and the residue was subjected to 
HPLC-MS b-porasil, 30 cm x 7.8 mm; Ac0Et:hexane 7:93; flow 
rate: 2.0 “in) to show peak at t~ 30.69 min. 
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(c) (2s,3R)-3-O-[(-)-(R)-a-Metho~a-(9-anthryl)ace~l]-2-me- 
thyloct-7-ynoic Methyl Ester (20). [ a ] ~ ~  -74.5 (c 0.1, CHCl3). EMS 
ndz (% relative intensity): 432 (M+, 5), 221 (loo), 208 (18), 206 (15), 
205 (12), 180 (16), 178 (19), 152 (12). HREIMS calcd for C27H2805 
d z  432.1936 (M+), found 432.1963. ‘H NMR (300.13 MHz, 
CDCl3): 6 0.43 (d, J = 7.1 Hz, 3 H), 1.19-1.67 (m, 4H), 1.96, (t, J 
= 2.6 Hz, 1 H), 2.18-2.27 (m, 3 H), 2.94 (s, 3 H), 3.41 (s, 3 H), 5.15 
(9, J =  6 Hz, 1 H), 6.28 (s, 1 H), 7.45-7.57 (m, 4 H), 8.01-8.03 (m, 
2 H), 8.48-8.59 (m, 3 H). I3C NMR (75.47 MHz, CDCl3): 6 11.7 
(c), 18.5 (t), 24.7 (t), 31.2 (t), 43.0 (d), 51.5 (c), 57.8 (c), 69.3 (d), 
75.0 (d), 77.4 (d), 84.1 (s), 124.9 (d), 125.4 (d), 126.8 (d), 127.3 (s), 
129.5 (d), 129.6 (d), 130.9 (s), 131.8 (s) 170.9 (s), 173.5 (s). 
(d) (ur,3s)-3-o-[(-)-(R)-a-Metho~-a-(9-anthryl)acetyl]-2-me- 
thyloct-7-ynoic Methyl Ester (21). [alD= +20.1 (c 0.1, CHC13). EMS 
d z  (% relative intensity): 432 (Mt, 18), 221 (loo), 206 (14), 205 (9), 
178 (18). HREIMS d z  432.1963 for C27Hz805 (calcd 432.1936). ‘H 
NMR (300.13 MHz, CDCl3): 6 0.50 (m, 2 H), 1.01 (d, J =  7.0, 3 H), 
1.08 (m, 1 H), 1.22-1.30 (m, 1 H), 1.39-1.53 (m, 2 H), 1.69 (t, J =  
2.6, 1 H), 2.55, (dd, J =  7.1, 5.2, 1 H), 3.44 (s, 3 H), 3.64 (s, 3 H), 
5.13 (m, 1 H), 6.26 (s, 1 H), 7.45-7.56 (m, 4 H), 8.00-8.03 (m, 2 H), 
8.47-8.54 (m, 3 H). 13C NMR (75.47 MHz, CDC13): 6 12.4 (c), 17.9 
(t), 23.7 (t), 30.7 (t), 43.5 (d), 52.6 (c), 58.2 (c), 69.0 (d), 74.9 (d), 
77.8 (d), 84.0 (s), 124.7 (d), 125.7 (d), 127.2 (d), 127.8 (s), 129.8 (d), 
129.9 (d), 131.0 (s), 132.0 (s), 171.5 (s), 174.6 (s). 
(e) Separation of the Mixture of 3-O-[(-)-(R)-a-Methoxy-a-(9- 
anthryl)acetyl]-2-methyloct-7-ynoic Methyl Esters (18-21) by HPLC- 
MS. A mixture of the synthetic isomers was separated by HJ?LC-MS 
(u-porasil, 30 cm x 7.8 mm; Ac0Et:hexane 7:93; flow rate: 2.0 mW 
min) showing the following retention times: (S,R) 28.09 min, ( R S )  
30.93 min, (R,S) 41.74 min, and (S,S) 46.54 min. 

